Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Carroll

Showing results (61-70 of 588) with videos related to

Pageof 59
Sort By:
The Journal of Urology|June 11, 2005
Update on chemotherapy for advanced bladder cancerJonathan E Rosenberg, Peter R Carroll, Eric J Small
Current Opinion in Urology|March 12, 2014
Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancerChristopher J Welty, Matthew R Cooperberg, Peter R Carroll
Nature Reviews. Urology|November 29, 2024
Time is on our side - rethinking the concept of time to treatment for prostate cancerNynikka R Palmer, Peter R Carroll, Samuel L Washington
Urology|September 17, 2002
A review of measurement of patient preferences for treatment outcomes after prostate cancerDeborah P Lubeck, Gary D Grossfeld, Peter R Carroll
The Medical Clinics of North America|March 31, 2004
Evaluation of the patient with hematuriaEdward J Yun, Maxwell V Meng, Peter R Carroll
BJU International|August 18, 2009
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized diseaseSima P Porten, Matthew R Cooperberg, Peter R Carroll
The Journal of Urology|May 19, 2010
Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized diseaseAdam C Reese, Matthew R Cooperberg, Peter R Carroll
The Journal of Urology|March 18, 2008
Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSUREBadrinath R Konety, Janet E Cowan, Peter R Carroll, et al.
The Canadian Journal of Urology|October 21, 2019
Germline testing in those at risk of prostate cancerPeter R Carroll, John S Witte, J Kellogg Parsons
European Urology|July 6, 2020
Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51Carissa E Chu, Peter E Lonergan, Peter R Carroll
Pageof 59

Showing results (61-70 of 588) with videos related to

Sort By:
Pageof 59
The Journal of Urology|June 11, 2005
Update on chemotherapy for advanced bladder cancerJonathan E Rosenberg, Peter R Carroll, Eric J Small
Current Opinion in Urology|March 12, 2014
Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancerChristopher J Welty, Matthew R Cooperberg, Peter R Carroll
Nature Reviews. Urology|November 29, 2024
Time is on our side - rethinking the concept of time to treatment for prostate cancerNynikka R Palmer, Peter R Carroll, Samuel L Washington
Urology|September 17, 2002
A review of measurement of patient preferences for treatment outcomes after prostate cancerDeborah P Lubeck, Gary D Grossfeld, Peter R Carroll
The Medical Clinics of North America|March 31, 2004
Evaluation of the patient with hematuriaEdward J Yun, Maxwell V Meng, Peter R Carroll
BJU International|August 18, 2009
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized diseaseSima P Porten, Matthew R Cooperberg, Peter R Carroll
The Journal of Urology|May 19, 2010
Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized diseaseAdam C Reese, Matthew R Cooperberg, Peter R Carroll
The Journal of Urology|March 18, 2008
Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSUREBadrinath R Konety, Janet E Cowan, Peter R Carroll, et al.
The Canadian Journal of Urology|October 21, 2019
Germline testing in those at risk of prostate cancerPeter R Carroll, John S Witte, J Kellogg Parsons
European Urology|July 6, 2020
Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51Carissa E Chu, Peter E Lonergan, Peter R Carroll
Pageof 59